PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 234 filers reported holding PDL BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,169,856,000 | -34.5% | 927,289 | -17.7% | 0.16% | -36.7% |
| Q1 2018 | $3,312,325,000 | +16.4% | 1,126,641 | +8.5% | 0.25% | +12.2% |
| Q4 2017 | $2,844,591,000 | +1889.8% | 1,038,172 | +2361.9% | 0.22% | +1741.7% |
| Q3 2017 | $142,956,000 | +107385.7% | 42,170 | +167.7% | 0.01% | -85.4% |
| Q4 2013 | $133,000 | – | 15,753 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |